Spots Global Cancer Trial Database for cytomegalovirus
Every month we try and update this database with for cytomegalovirus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis | NCT01248598 | Cytomegalovirus Epstein-Barr Vi... Herpesvirus Inf... | 18 Years - 80 Years | Rambam Health Care Campus | ||
| Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy | NCT00366717 | Cancer Cytomegalovirus | 20 Years - | Mackay Memorial Hospital | ||
| Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens | NCT02864368 | Glioblastoma Glioblastoma Mu... | 5-day TMZ 21-day TMZ PEP-CMV: Compon... Tetanus-Diphthe... Tetanus Pre-Con... PEP-CMV: Compon... | 18 Years - | Duke University | |
| A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) | NCT00990496 | Glioblastoma Mu... | Fludarabine Cyclophosphamid... CMV Specific Cy... | 5 Years - 65 Years | Milton S. Hershey Medical Center | |
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients | NCT04116411 | Glioblastoma Mu... | Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta... | 18 Years - | Karolinska Institutet | |
| Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease | NCT00222378 | Crohn's Disease Ulcerative Coli... | 18 Years - 70 Years | University of Miami | ||
| Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens | NCT02864368 | Glioblastoma Glioblastoma Mu... | 5-day TMZ 21-day TMZ PEP-CMV: Compon... Tetanus-Diphthe... Tetanus Pre-Con... PEP-CMV: Compon... | 18 Years - | Duke University | |
| Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens | NCT02864368 | Glioblastoma Glioblastoma Mu... | 5-day TMZ 21-day TMZ PEP-CMV: Compon... Tetanus-Diphthe... Tetanus Pre-Con... PEP-CMV: Compon... | 18 Years - | Duke University | |
| Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation | NCT02210065 | Leukemia Lymphoma | Cytomegalovirus... | 18 Years - | M.D. Anderson Cancer Center | |
| The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis | NCT01504113 | Psoriasis | 20 Years - 90 Years | National Taiwan University Hospital | ||
| Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT | NCT06075927 | CMV Infection EBV Infection Stem Cell Trans... | Virus specific ... | 18 Years - 70 Years | Peking University People's Hospital | |
| UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients | NCT01622595 | Aspergillosis Candidemia C. Difficile | 18 Years - | University of Arkansas | ||
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients | NCT04116411 | Glioblastoma Mu... | Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta... | 18 Years - | Karolinska Institutet | |
| UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients | NCT01622595 | Aspergillosis Candidemia C. Difficile | 18 Years - | University of Arkansas | ||
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV | NCT01535885 | Epstein-Barr Vi... Adenovirus Cytomegalovirus... | Cytotoxic T Lym... | - 22 Years | Medical College of Wisconsin | |
| Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient | NCT03806764 | Cytomegalovirus... Haematological ... Organ or Tissue... Immune Suppress... | Blood sampling | 18 Years - | Melbourne Health | |
| A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) | NCT00990496 | Glioblastoma Mu... | Fludarabine Cyclophosphamid... CMV Specific Cy... | 5 Years - 65 Years | Milton S. Hershey Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
